Nivolumab Doubles Disease-Free Survival When Residual Esophageal Cancer Lurks

NEW YORK (Reuters Health) – When esophageal or gastroesophageal-junction cancer remains a threat after chemoradiotherapy and surgery because of residual

Read more

Primary Care Clinicians Neglect Hearing Loss, Survey Finds

Most adults in the United States have not been asked about their hearing by their primary care provider in the

Read more